Alivamab Discovery Services Competitors and Similar CompaniesClear all
Alivamab Discovery Services's competitors and similar companies include Domain Therapeutics, Absci and Cingulate.
 Alivamab Discovery Services AlivaMab Discovery Services is a contract research organization that offers human therapeutic antibody discovery and development services. |  Cingulate Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety. | |||
Founding Date | Founding Date 2018 | Founding Date 2001 | Founding Date 2011 | Founding Date 2021 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA | Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US | Locations Kansas City, US HQ Morristown, US |
Employees | Employees 343% increase | Employees 811% decrease | Employees 1561% increase | Employees 13 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 487.2 m | Valuation ($) 13.2 m |
Financial | ||||
Net income | Net income N/A | Net income N/A | Net income ($115.2m) (FY, 2025) | Net income ($22.4m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 41.5m | Total funding raised $ 217.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Domain Therapeutics
HQ
Illkirch-Graffenstaden, FR
Employees
81↓ 1% decrease
Domain Therapeutics is a biopharmaceutical company.
View company
Absci
HQ
Vancouver, US
Employees
156↑ 1% increase
AbSci is a company that provides generative AI drug-creation solutions.
View companyCingulate
HQ
Kansas City, US
Employees
13
Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety.
View company